Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation
To initiate T cell-mediated immunity, dendritic cells (DCs) present antigens to T cells through the establishment of an immune synapse (IS). While events behind IS formation in T cells are well understood, the organization of IS components at the DC membrane remains ill-defined. Galectins modulate immune responses via glycan-(in)dependent interactions but the molecular mechanisms underlying their function in DC-mediated T cell activation, are poorly described. Here, we demonstrate that intracellular galectin-9 (gal9) in DCs is required for CD4<sup>+</sup> T cell activation through its interaction with the HLA-DR alpha- and beta- cytoplasmic domains, as supported by coimmunoprecipitation, mass spectrometry, and NMR analyses. Live-cell imaging revealed gal9-depleted DCs fail to establish stable ISs with T cells, reducing T cell activation and proliferation. Notably, HLA-DR membrane lateral mobility and recruitment to the IS was diminished in DCs lacking gal9. Conditional gal9 knockout in DCs led to enhanced tumor growth in vivo, underscoring a role for gal9 in T cell-dependent antitumor immunity. Collectively, this study reports gal9-mediated HLA-DR organization at the DC synapse, uncovering a mechanism through which intracellular galectins coordinate immune receptor positioning to enhance CD4<sup>+</sup> T cell activation.
Authors
- Martijn Verdoes (ORCID: https://orcid.org/0000-0001-8753-3528)
- René Classens (ORCID: https://orcid.org/0009-0004-0143-6030)
- Mayukha Bathini (ORCID: https://orcid.org/0000-0003-0501-4711)
- Andrea Rodgers Furones (ORCID: https://orcid.org/0000-0002-0635-4470)
- Rik G.H. Lindeboom (ORCID: https://orcid.org/0000-0002-3660-504X)
- Ana Ardá (ORCID: https://orcid.org/0000-0003-3027-7417)
- Zacharias Wijfjes (ORCID: https://orcid.org/0000-0001-5705-1624)
- Annemiek B. van Spriel (ORCID: https://orcid.org/0000-0002-3590-2368)
- Lona J. Kroese
- Laia Querol Cano (ORCID: https://orcid.org/0000-0002-7650-9407)
- Jesús Jiménez‐Barbero (ORCID: https://orcid.org/0000-0001-5421-8513)
- Sandra Delgado (ORCID: https://orcid.org/0000-0001-5848-6590)
- Mirane Florencio-Zabaleta (ORCID: https://orcid.org/0009-0000-6058-2936)
- Guido van Mierlo (ORCID: https://orcid.org/0000-0001-5883-0339)
- Kristina Fedorova (ORCID: https://orcid.org/0009-0001-0541-403X)
- Thijs Brands (ORCID: https://orcid.org/0009-0008-0886-4125)
- Guusje van Gameren (ORCID: https://orcid.org/0009-0007-2929-6289)
Institutions
- Ikerbasque (ES)
- Radboud University Nijmegen (NL)
- University of the Basque Country (ES)
- Radboud University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Oncode Institute (NL)
- CIC bioGUNE (ES)
- Cancer Genomics Centre (NL)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1073/pnas.2501381122
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Research Institute
- Ministerie van Volksgezondheid, Welzijn en Sport
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Radboud Universitair Medisch Centrum
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación